Anxiety Disorders Completed Phase 4 Trials for Escitalopram (DB01175)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00105586Drug Therapy for Generalized Anxiety Disorder Among the ElderlyTreatment
NCT01477203Multimodal Assessment of Neurobiological Markers for Psychiatric DisordersDiagnostic